hotspot -WSS

hotspot

author：leisure time 2025-09-27 11:29:26 - browse：6

OVIEDO, Fla. -- Raymond Cassagnol, a Haitian pilot and a member of the Tuskegee Airmen, the famed group of Black military aviators during World War II, has died. He was 102.

Cassagnol died June 24 at his home in Florida, according his daughter, Dominique Cassagnol Ballacchino.

Cassagnol was one of three Haitian servicemen initially selected to join an experimental program in Tuskegee, Alabama, for Black soldiers seeking to train as pilots after the Army Air Corps was forced to admit Black Americans.

The Haitian serviceman wrote in his memoir that he was shocked by the prejudice he encountered in the American South and opted to stay close to the training field.

“During that time, color prejudice was in full swing, and even the church did not escape segregation: Whites in the front, blacks in the back. Nevertheless, the choir members were blacks, and the soprano was applauded at the end of Mass. This is why I was careful not to frequent places where I could be humiliated,” he wrote in “Memoires d’un Revolutionnaire.”

Cassagnol graduated from the Tuskegee program and received his pilot wings on July 28, 1943. He returned to Haiti and flew missions for his country, patrolling for submarines.

A revolutionary who opposed the brutal Duvalier dictatorship, Cassagnol later immigrated to the United States in 1960s to keep his family safe.

“I fought all the dictators,” he told the Orlando-Sentinel in 2000 of his service during and after World War II.

Ballacchino said her father was courageous and dedicated to his family and the cause of Haiti.

“He never gave up. He never gave up. He was always a fighter,” Ballacchino said.

More than 900 men trained at Tuskegee from 1940 to 1946. The Tuskegee Airmen have been the subject of books, movies and documentaries highlighting their courage in the air and the discrimination they faced in the United States while fighting for freedom abroad.

Previous article： How to save PrEP access — and even expand it
Next article： Emergency medicine has repudiated 'excited delirium.' Now what?

entertainment

knowledge

WSS

Biotech stock slump in 2023: awaiting the turnaround

Drug for rare kidney disease narrowly misses mark in clinical trial

Lasker Awards 2023: Winners in biomedical research

Testing for cancer recurrence creates a new limbo for patients

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

focus

hotspot

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Chimpanzees, like humans and whales, get menopause: Study

Medicare proposal to cover medical devices draws a mixed reaction

Emergency workers more likely to restrain Black patients: study

DIEP, the 'gold standard' of breast reconstruction, is under threat

Meta's Zuckerberg and Chan on track to put $50 billion into science

Anesthesiologist group: stop taking Ozempic before surgery

How Vertex's cystic fibrosis drug is changing patients' lives

Guidelines to prevent youth baseball injuries need more muscle

Why are Kaiser Permanente staff considering a strike?

focus

Telehealth options flood the market as retailers push virtual care

CDC advisers recommend seasonal use of Pfizer RSV shot

EpiPen alternative approval delay highlights citizen petition issue

Readout Newsletter: XBI biotech index, Akero Therapeutics

Emergency medicine has repudiated 'excited delirium.' Now what?

Medical student insurance fails on mental health care coverage

entertainment

explore

knowledge

focus